Two non-intoxicating compounds found in cannabis may help address one of the world’s most common chronic liver diseases. Scientists recently discovered that CBD and CBG could significantly improve how liver cells manage energy and remove harmful waste.
Researchers from the Hebrew University of Jerusalem conducted the study at the university’s School of Pharmacy within the Faculty of Medicine. Their findings suggest that these cannabis-derived compounds may support healthier liver function by improving cellular metabolism and activating the liver’s internal cleanup systems.
The discovery arrives at a critical time. Fatty liver disease now affects roughly one third of adults worldwide. Medical professionals increasingly view it as one of the fastest growing metabolic health threats.
However, effective treatments remain limited. Because of this, researchers continue searching for safe and accessible solutions.
Fatty Liver Disease Is Rapidly Expanding Worldwide
Metabolic dysfunction associated steatotic liver disease, known as MASLD, represents the most common chronic liver condition globally. The disease develops when excess fat accumulates in the liver, interfering with normal metabolic processes.
Several modern health factors drive the condition. Obesity, high blood pressure, and insulin resistance remain the strongest contributors. Additionally, sedentary lifestyles and poor diets accelerate the disease’s progression.
Doctors typically recommend lifestyle adjustments such as diet improvements and increased exercise. While effective, maintaining these habits consistently can prove difficult for many patients.
As a result, the medical community continues exploring pharmaceutical and plant-based treatments that could support long-term metabolic health.
This is where cannabinoids like CBD and CBG are gaining scientific attention.
How CBD and CBG Improve Liver Energy Systems
Researchers discovered that CBD and CBG do far more than reduce fat accumulation in the liver. Instead, the compounds appear to influence the liver’s internal energy management systems.
Scientists refer to this process as metabolic remodeling. Essentially, the compounds help liver cells adapt to metabolic stress while maintaining normal function.
One key discovery involved the molecule phosphocreatine. This compound acts as an emergency energy reserve within cells.
During periods of metabolic strain, phosphocreatine helps cells maintain stability and continue operating normally. Interestingly, the liver does not typically rely heavily on this system.
However, CBD and CBG increased phosphocreatine levels significantly. This change appears to give liver cells additional energy protection during metabolic stress such as high-fat diets.
The finding surprised researchers and highlights a previously unknown interaction between cannabinoids and liver metabolism.
Restoring the Liver’s Cellular Cleanup Process
Another major discovery involved the liver’s cellular recycling system.
Inside each liver cell are structures called lysosomes. These act as waste processing centers that break down unwanted materials.
Within lysosomes are enzymes called cathepsins. Their job is to break down fats, proteins, and damaged cellular components.
When these enzymes function properly, the liver efficiently removes harmful metabolic waste.
However, fatty liver disease often disrupts this cleanup process.
The study found that CBD and CBG reactivate cathepsins and restore lysosomal activity. As a result, liver cells regain their ability to process and remove harmful fat molecules.
Researchers observed significant reductions in several dangerous lipids.
These included triglycerides and ceramides. Ceramides are particularly concerning because they contribute to inflammation and insulin resistance.
Reducing these molecules could play a major role in preventing liver damage.
CBD and CBG Produce Different Metabolic Benefits
Although both cannabinoids showed strong metabolic benefits, they produced slightly different effects.
Both CBD and CBG helped stabilize blood sugar levels and improve glucose metabolism. This supports healthier insulin activity throughout the body.
However, CBG demonstrated even stronger metabolic improvements in several areas.
The compound significantly reduced body fat mass and improved insulin sensitivity. It also lowered total cholesterol levels and reduced harmful LDL cholesterol.
These findings suggest that CBG may hold particular promise for treating metabolic disorders linked to fatty liver disease.
Why This Discovery Matters for Cannabis Science
The study represents another milestone in the expanding field of cannabinoid research.
For decades, cannabis science focused primarily on THC and its psychoactive effects. However, non-intoxicating cannabinoids now attract increasing medical interest.
CBD has already gained global recognition for potential therapeutic uses. Meanwhile, CBG remains less widely known but is gaining attention as researchers uncover new biological effects.
Importantly, both compounds produce these benefits without causing intoxication.
This distinction could make them appealing for pharmaceutical development and broader medical use.
As scientists continue studying cannabinoids, new treatment pathways may emerge for conditions once thought unrelated to cannabis.
What This Means for the Cannabis Industry
Scientific discoveries like this carry major implications for the cannabis industry.
First, they strengthen the legitimacy of cannabinoid research in mainstream medicine. As evidence grows, pharmaceutical companies and research institutions are investing more resources into studying cannabis compounds.
Second, medical discoveries expand the market potential for non-intoxicating cannabinoids. Products containing CBD and CBG already exist across wellness markets. However, clinical validation could push these compounds into pharmaceutical territory.
Finally, the research reinforces the importance of minor cannabinoids. Beyond THC and CBD, cannabis contains more than 100 cannabinoids that may hold therapeutic value.
Future medical breakthroughs may emerge from these lesser-known compounds.
Black Cannabis Magazine is your go-to platform for cannabis culture, news, and lifestyle content with a focus on diversity and inclusion. For more information, visit www.blackcannabismagazine.com.
Copyright 2026 Black Cannabis Magazine. Distributed by Hazey Taughtme, LLC.
